Ointment Mucopain
Reading File
Finding Sources
Searching the Web
Mucopain ointment benzocaine uses dose pharmacology
Reading Web Page
https://www.practo.com/medicine-info/mucopain-0-2-ointment-3…
Finding Sources
I now have comprehensive information from both the web and medical textbook sources. Here is a complete overview:
Mucopain Ointment (Benzocaine 0.2%)
What is it?
Mucopain 0.2% Ointment is a topical local anesthetic manufactured by ICPA Health Products Ltd. Its active ingredient is Benzocaine (ethyl aminobenzoate), an ester-type local anesthetic. A higher-concentration formulation, Mucopain Gel 20%, is also available for oral/mucosal use.
Mechanism of Action
Benzocaine blocks sodium channels in nerve membranes, preventing depolarization and transmission of pain signals from the peripheral site to the brain. It does not cause loss of consciousness - it acts only locally at the site of application. Its onset is very rapid (under 1 minute) and duration is short (approximately 5-15 minutes), as noted in Barash's Clinical Anesthesia.
Uses / Indications
| Condition | Details |
|---|---|
| Local anesthesia (pre-procedure) | Applied before minor surgical/dental procedures |
| Oral ulcers & mouth sores | Numbs painful mucosal lesions |
| Sore throat | Temporary pain relief |
| Hemorrhoids | Reduces rectal pain/irritation |
| Sunburn / minor burns | Surface pain relief |
| Teething pain | Gum application (caution in children) |
| Insect bites / minor cuts | Itch and pain relief |
| Vaginal / rectal irritation | Topical relief |
| Ingrown toenails | Local surface numbing |
Dosage & Administration
- Apply topically to the affected area as needed.
- Maximum: 4 times per day - do not exceed this frequency.
- Onset: Within 1 minute of application.
- Duration: 5-15 minutes.
- Apply the minimum amount required to achieve pain relief.
- Not for use in children under 2 years without medical advice.
Side Effects
Common:
- Burning or stinging at application site
- Skin irritation / contact dermatitis
- Metallic or altered taste (with oral use)
- Dry mouth
- Mild headache
Serious (Rare):
- Methemoglobinemia - a potentially life-threatening condition where hemoglobin loses its ability to carry oxygen, causing bluish discoloration of skin (cyanosis), shortness of breath, and fatigue. This is a well-documented risk of benzocaine, highlighted across multiple textbooks including Morgan & Mikhail's Clinical Anesthesiology and Goodman & Gilman's. Many hospitals restrict benzocaine sprays during endoscopic procedures for this reason.
- Edema (swelling)
- Urticaria (hives)
- Severe allergic reaction (anaphylaxis - rare)
Overdose signs: Irregular heartbeat, seizures, coma, respiratory failure - requires emergency care.
Contraindications
- Known allergy to benzocaine or any ester-type local anesthetic (e.g., procaine, tetracaine)
- History of methemoglobinemia
- Bacterial infections at the application site (secondary infection risk)
- Should not be applied to breast/nipple in breastfeeding mothers
Warnings & Special Populations
| Population | Warning |
|---|---|
| Pregnancy | Not recommended unless absolutely necessary; discuss risk-benefit with doctor |
| Breastfeeding | Do not apply to nipple/breast area - infant may ingest the drug |
| Children < 2 years | Avoid unless directed by a physician |
| Methemoglobinemia history | Absolute contraindication |
Drug Interactions
- Sodium Nitrite - increased methemoglobinemia risk
- Prilocaine - additive methemoglobinemia risk
- Para-aminobenzoic acid (PABA) derivatives - may interfere with sulfonamide antibiotics (benzocaine is metabolized to PABA)
Key Clinical Points
- Benzocaine is an ester-class local anesthetic (not an amide) - allergic patients to amides (lidocaine, bupivacaine) are not necessarily allergic to it, but cross-reactivity within ester class exists.
- The methemoglobinemia risk is the most clinically significant concern - monitor for signs of cyanosis, especially with large-area or mucosal application.
- Treatment of methemoglobinemia caused by benzocaine: IV methylene blue 1-2 mg/kg.
- Effect lasts only 5-15 minutes - it is not suitable for prolonged pain management.
- No habit-forming potential reported.
This is a shared conversation. Sign in to Orris to start your own chat.